RAND analyses and makes recommendations on data collection, the expansion of evidence-based treatment and alternatives to repressive responses to drug use.

The EMCDDA reports on public health challenges, including the heavy burden of premature preventable deaths by overdose.

UNODC compiles data on thriving drug markets, noting a 30% rise in use over the last decade yet remaining mostly silent on human rights impact of drug control.

The EMCDDA reports on the rapid growth of ephedrine and methamphetamine production in Afghanistan and discusses potential implications.

Despite costly counter-narcotics programmes and international cooperation, drug markets are gaining ground in East and South-East Asia.